JHVEPhoto/iStock Editorial by way of Getty Photos
- Novo Nordisk press launch (NVO): 1H GAAP EPS of DKK 10.17.
- Income of DKK 133.41B (+23.9% Y/Y) and by 25% at fixed change charges.
- For the 2024 outlook, gross sales progress is now anticipated to be 22-28% at CER, and working revenue progress is now anticipated to be 20-28% at CER. Development reported in Danish kroner is now anticipated to be 1 proportion level decrease than at CER progress for each gross sales and working revenue.
